Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study

World Journal of Gastroenterology

Volumn 18, Issue 12, 2012, Pages 1404-1409

  Jiang, Xiang Jun ^a   Song, Ming Quan ^a   Xin, Yong Ning ^a   Gao, Yu Qiang ^a   Niu, Zi Yu ^a   Tian, Zi Bin ^b  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Case control study; Chemoradiotherapy; Esophageal cancer; Stents; Three dimensional imaging

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DYSPHAGIA; ENDOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS PERFORATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INOPERABLE CANCER; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PATIENT ASSESSMENT; RADIATION DOSE; REFLUX ESOPHAGITIS; RESTENOSIS; STENT; THORAX PAIN; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 84859043764     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i12.1404     Document Type: Article

References (16)

1. Lu XJ, Chen ZF, Guo CL, Li SS, Bai WL, Jin GL, Wang YX, Meng FS, Gao F, Hou J. Endoscopic survey of esophageal cancer in a high-risk area of China. World J Gastroenterol 2004; 10: 2931-2935
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150
3. Katsoulis IE, Karoon A, Mylvaganam S, Livingstone JI. Endoscopic palliation of malignant dysphagia: a challenging task in inoperable oesophageal cancer. World J Surg Oncol 2006; 4: 38
4. Fietkau R. Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus. Onkologie 2004; 27: 39-44
5. Maroju NK, Anbalagan P, Kate V, Ananthakrishnan N. Improvement in dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol 2006; 25: 62-65
6. Ludwig D, Dehne A, Burmester E, Wiedemann GJ, Stange EF. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 1998; 13: 583-588
7. Wada S, Noguchi T, Takeno S, Moriyama H, Hashimoto T, Uchida Y, Kawahara K. Is a metallic stent useful for non resectable esophageal cancer? Ann Thorac Cardiovasc Surg 2004; 10: 224-228
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. (eds): AJCC Cancer Staging Manual (seventh edition). New York, NY: Springer-Verlag, 2009: 101-103
9. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156
10. Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study. Ann Surg Oncol 2008; 15: 576-582
11. Iwase H, Shimada M, Nakamura M, Nakarai K, Iyo T, Kaida S, Indo T, Kato E, Horiuchi Y, Kusugami K. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy. Int J Clin Oncol 2003; 8: 305-311
12. Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Nam TK, Lee JJ, Kim HJ, Chung IJ. Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. Dis Esophagus 2008; 21: 697-703
13. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-1174
14. Lecleire S, Di Fiore F, Ben-Soussan E, Antonietti M, Hellot MF, Paillot B, Lerebours E, Ducrotté P, Michel P. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Aliment Pharmacol Ther 2006; 23: 1693-1702
15. Nishimura Y, Nagata K, Katano S, Hirota S, Nakamura K, Higuchi F, Soejima T, Sai H. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 2003; 56: 1327-1332
16. Sumiyoshi T, Gotoda T, Muro K, Rembacken B, Goto M, Sumiyoshi Y, Ono H, Saito D. Morbidity and mortality after self-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy. Gastrointest Endosc 2003; 57: 882-885